RU2015136256A - Противовирусные соединения - Google Patents
Противовирусные соединения Download PDFInfo
- Publication number
- RU2015136256A RU2015136256A RU2015136256A RU2015136256A RU2015136256A RU 2015136256 A RU2015136256 A RU 2015136256A RU 2015136256 A RU2015136256 A RU 2015136256A RU 2015136256 A RU2015136256 A RU 2015136256A RU 2015136256 A RU2015136256 A RU 2015136256A
- Authority
- RU
- Russia
- Prior art keywords
- dichloro
- diamine
- phenyl
- triazol
- ylamino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/14—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Claims (35)
1. Соединение, выбранное из группы, состоящей из:
N3-(4-бромо-3-хлор-5-трифторметил-фенил)-N5-(4-трифторметил-бензил)-1H-[1,2,4]триазол-3,5-диамин;
N3-(3,5-дихлор-фенил)-N5-фуран-2-илметил-1Н-[1,2,4]триазол-3,5-диамин;
N3-(3,5-дихлор-фенил)-N5-(5-метил-фуран-2-илметил)-1Н-[1,2,4]триазол-3,5-диамин;
N5-(5-хлор-2-трифторметил-бензил)-N3-(3,5-дихлор-фенил)-1H-[1,2,4]триазол-3,5-диамин;
N5-(5-хлор-пиридин-2-илметил)-N3-(3,5-дихлор-фенил)-1Н-[1,2,4]триазол-3,5-диамин;
(5-{[5-(3,5-дихлор-фениламино)-2Н-[1,2,4]триазол-3-иламино]-метил}-пиридин-2-ил)-карбаминовой кислоты трет-бутиловый эфир;
4-{[5-(3,5-дихлор-фениламино)-2Н-[1,2,4]триазол-3-иламино]-метил}-бензойной кислоты трет-бутиловый эфир;
2-{[5-(3,5-дихлор-фениламино)-2Н-[1,2,4]триазол-3-иламино]-метил}-бензойной кислоты трет-бутиловый эфир;
N5-бензил-N3-(3,5-дихлор-фенил)-1H-[1,2,4]триазол-3,5-диамин;
N5-(6-амино-пиридин-3-илметил)-N3-(3,5-дихлор-фенил)-1Н-[1,2,4]триазол-3,5-диамин;
N3-(3,5-дихлор-фенил)-N5-(1-метил-1H-пиразол-4-илметил)-1H-[1,2,4]триазол-3,5-диамин;
4-{[5-(3,5-дихлор-фениламино)-2Н-[1,2,4]триазол-3-иламино]-метил}-бензойная кислота;
3-{[5-(3,5-дихлор-фениламино)-2Н-[1,2,4]триазол-3-иламино]-метил}-бензойная кислота;
2-{[5-(3,5-дихлор-фениламино)-2Н-[1,2,4]триазол-3-иламино]-метил}-бензойная кислота;
N3-(3,5-дихлор-фенил)-N5-(4-метансульфонил-бензил)-1Н-[1,2,4]триазол-3,5-диамин;
4-{[5-(3,5-дихлор-фениламино)-2Н-[1,2,4]триазол-3-иламино]-метил}-бензонитрил;
4-{[5-(3,5-дихлор-фениламино)-2Н-[1,2,4]триазол-3-иламино]-метил}-N,N-диметил-бензолсульфонамид;
N-трет-бутил-4-{[5-(3,5-дихлор-фениламино)-2Н-[1,2,4]триазол-3-иламино]-метил}-бензолсульфонамид;
N5-(3-хлор-4-трифторметил-бензил)-N3-(3,5-дихлор-фенил)-1Н-[1,2,4]триазол-3,5-диамин;
N3-(3,5-дихлор-фенил)-N5-[4-(пирролидин-1-сульфонил)-бензил]-1Н-[1,2,4]триазол-3,5-диамин;
N3-(3,5-дихлор-фенил)-N5-[4-(морфолин-4-сульфонил)-бензил]-1Н-[1,2,4]триазол-3,5-диамин;
2,6-дихлор-4-[5-(4-трифторметил-бензиламино)-1Н-[1,2,4]триазол-3-иламино]-бензонитрил;
4-{[5-(3,5-дихлор-4-циано-фениламино)-2Н-[1,2,4]триазол-3-иламино]-метил}-бензойной кислоты трет-бутиловый эфир;
4-({5-[6-хлор-4'-(пропан-2-сульфонил)-2-трифторметил-бифенил-4-иламино]-2Н-[1,2,4]триазол-3-иламино}-метил)-бензойной кислоты трет-бутиловый эфир;
N3-(3,5-дихлор-фенил)-N5-(4-трифторметил-бензил)-1Н-[1,2,4]триазол-3,5-диамин;
N3-(3,5-дихлор-фенил)-N5-(3-трифторметил-бензил)-1Н-[1,2,4]триазол-3,5-диамин;
N3-(3,5-дихлор-фенил)-N5-(1-метансульфонил-пиперидин-4-ил)-1Н-[1,2,4]триазол-3,5-диамин;
4-[5-(3,5-дихлор-фениламино)-2Н-[1,2,4]триазол-3-иламино]-пиперидин-1-карбоновой кислоты трет-бутиловый эфир;
N3-(3,5-дихлор-фенил)-N5-пиперидин-4-ил-1Н-[1,2,4]триазол-3,5-диамин;
1-{4-[5-(3,5-дихлор-фениламино)-2Н-[1,2,4]триазол-3-иламино]-пиперидин-1-ил}-этанон; и
N3-(3,5-дихлор-фенил)-N5-пиримидин-5-илметил-1Н-[1,2,4]триазол-3,5-диамин.
2. Соединение по п. 1 для применения в качестве терапевтически активного вещества.
3. Соединение по п. 1 для лечения инфекции, вызванной вирусом гепатита C.
4. Фармацевтическая композиция, содержащая соединение по п. 1 и фармацевтически приемлемый эксципиент.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361772924P | 2013-03-05 | 2013-03-05 | |
US61/772,924 | 2013-03-05 | ||
PCT/EP2014/053780 WO2014135422A1 (en) | 2013-03-05 | 2014-02-27 | Antiviral compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2015136256A true RU2015136256A (ru) | 2017-04-10 |
Family
ID=50280353
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2015136256A RU2015136256A (ru) | 2013-03-05 | 2014-02-27 | Противовирусные соединения |
Country Status (11)
Country | Link |
---|---|
US (1) | US9428469B2 (ru) |
EP (1) | EP2964637B1 (ru) |
JP (1) | JP6018715B2 (ru) |
KR (1) | KR20150114566A (ru) |
CN (1) | CN105008350B (ru) |
BR (1) | BR112015021429A2 (ru) |
CA (1) | CA2900319A1 (ru) |
HK (1) | HK1216885A1 (ru) |
MX (1) | MX2015011193A (ru) |
RU (1) | RU2015136256A (ru) |
WO (1) | WO2014135422A1 (ru) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2898107A1 (en) * | 2013-03-06 | 2014-09-12 | F. Hoffmann-La Roche Ag | Antiviral compounds |
CN106467501B (zh) * | 2015-08-18 | 2018-10-26 | 中国医学科学院医药生物技术研究所 | 新型抗病毒化合物 |
JP6848504B2 (ja) * | 2017-02-15 | 2021-03-24 | 株式会社村田製作所 | 二次電池用電解液、二次電池、電池パック、電動車両、電力貯蔵システム、電動工具および電子機器 |
US11066404B2 (en) | 2018-10-11 | 2021-07-20 | Incyte Corporation | Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors |
WO2020168197A1 (en) | 2019-02-15 | 2020-08-20 | Incyte Corporation | Pyrrolo[2,3-d]pyrimidinone compounds as cdk2 inhibitors |
CN111621026A (zh) * | 2019-02-28 | 2020-09-04 | 南京农业大学 | 一种双功能钴配合物材料的制备方法及其电化学性能应用 |
US11472791B2 (en) | 2019-03-05 | 2022-10-18 | Incyte Corporation | Pyrazolyl pyrimidinylamine compounds as CDK2 inhibitors |
WO2020205560A1 (en) | 2019-03-29 | 2020-10-08 | Incyte Corporation | Sulfonylamide compounds as cdk2 inhibitors |
US11447494B2 (en) | 2019-05-01 | 2022-09-20 | Incyte Corporation | Tricyclic amine compounds as CDK2 inhibitors |
US11440914B2 (en) | 2019-05-01 | 2022-09-13 | Incyte Corporation | Tricyclic amine compounds as CDK2 inhibitors |
CR20220066A (es) | 2019-08-14 | 2022-11-28 | Incyte Corp | Compuestos de imidazolil pirimidinilamina como inhibidores de cdk2 |
WO2021072232A1 (en) | 2019-10-11 | 2021-04-15 | Incyte Corporation | Bicyclic amines as cdk2 inhibitors |
US11981671B2 (en) | 2021-06-21 | 2024-05-14 | Incyte Corporation | Bicyclic pyrazolyl amines as CDK2 inhibitors |
US11976073B2 (en) | 2021-12-10 | 2024-05-07 | Incyte Corporation | Bicyclic amines as CDK2 inhibitors |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1157256A (en) * | 1967-05-17 | 1969-07-02 | Leuna Werke Veb | Process for production of Substituted 1.2.4-Triazoles |
KR0174026B1 (ko) * | 1990-08-03 | 1999-02-01 | 나가야마 오사무 | 트리아졸 화합물 |
US6054472A (en) | 1996-04-23 | 2000-04-25 | Vertex Pharmaceuticals, Incorporated | Inhibitors of IMPDH enzyme |
US5807876A (en) | 1996-04-23 | 1998-09-15 | Vertex Pharmaceuticals Incorporated | Inhibitors of IMPDH enzyme |
EP0902782A1 (en) | 1996-04-23 | 1999-03-24 | Vertex Pharmaceuticals Incorporated | Urea derivatives as inhibitors of impdh enzyme |
SE508697C2 (sv) | 1996-07-19 | 1998-10-26 | Ericsson Telefon Ab L M | Förfarande och anordning för tidskontinuerlig filtrering i digital CMOS-process |
UA79749C2 (en) | 1996-10-18 | 2007-07-25 | Vertex Pharma | Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
GB9623908D0 (en) | 1996-11-18 | 1997-01-08 | Hoffmann La Roche | Amino acid derivatives |
US6010848A (en) | 1997-07-02 | 2000-01-04 | Smithkline Beecham Corporation | Screening methods using an atpase protein from hepatitis C virus |
IL134233A0 (en) | 1997-08-11 | 2001-04-30 | Boehringer Ingelheim Ca Ltd | Hepatitis c inhibitor peptide analogues |
US6492423B1 (en) | 1998-07-27 | 2002-12-10 | Istituto Di Ricerche Di Biologia Molecolare Pangeletti Spa | Diketoacid-derivatives as inhibitors of polymerases |
US6323180B1 (en) | 1998-08-10 | 2001-11-27 | Boehringer Ingelheim (Canada) Ltd | Hepatitis C inhibitor tri-peptides |
ID27787A (id) | 1998-08-21 | 2001-04-26 | Viro Pharma Inc | Senyawa, komposisi dan metode untuk pengobatan atau pencegahan infeksi yang disebabkan oleh virus dan penyakit-penyakit yang berkaitan |
JP2002524423A (ja) | 1998-09-04 | 2002-08-06 | バイロファーマ・インコーポレイテッド | ウイルス感染および関連疾患の治療および予防方法 |
AU751457B2 (en) | 1998-09-25 | 2002-08-15 | Viropharma Incorporated | Methods for treating or preventing viral infections and associated diseases |
CZ301802B6 (cs) | 1999-03-19 | 2010-06-30 | Vertex Pharmaceuticals Incorporated | Deriváty mocoviny jako inhibitory IMPDH a farmaceutické prostredky s jejich obsahem |
WO2001032153A2 (en) | 1999-11-04 | 2001-05-10 | Shire Biochem Inc. | Method for the treatment or prevention of flaviviridae viral infection using nucleoside analogues |
AU2001261377A1 (en) | 2000-05-10 | 2001-11-20 | Smith Kline Beecham Corporation | Novel anti-infectives |
US6448281B1 (en) | 2000-07-06 | 2002-09-10 | Boehringer Ingelheim (Canada) Ltd. | Viral polymerase inhibitors |
DE10036949C2 (de) * | 2000-07-28 | 2002-06-06 | Agfa Gevaert Ag | Fotografisches Silberhalogenidmaterial |
SV2003000617A (es) | 2000-08-31 | 2003-01-13 | Lilly Co Eli | Inhibidores de la proteasa peptidomimetica ref. x-14912m |
DE10123586A1 (de) * | 2001-05-08 | 2002-11-28 | Schering Ag | 3,5-Diamino-1,2,4-triazole als Kinase Inhibitoren |
US6881741B2 (en) | 2001-06-11 | 2005-04-19 | Virochem Pharma Inc. | Compounds and methods for the treatment or prevention of Flavivirus infections |
JP2005500287A (ja) | 2001-06-11 | 2005-01-06 | シャイアー バイオケム インコーポレイテッド | Flavivirus感染の処置または予防のための化合物および方法 |
AR035543A1 (es) | 2001-06-26 | 2004-06-16 | Japan Tobacco Inc | Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con |
WO2003007945A1 (en) | 2001-07-20 | 2003-01-30 | Boehringer Ingelheim (Canada) Ltd. | Viral polymerase inhibitors |
EP2335700A1 (en) | 2001-07-25 | 2011-06-22 | Boehringer Ingelheim (Canada) Ltd. | Hepatitis C virus polymerase inhibitors with a heterobicylic structure |
JP2005511573A (ja) | 2001-11-02 | 2005-04-28 | グラクソ グループ リミテッド | Hcv阻害剤としての4−(5−員)−ヘテロアリールアシルピロリジン誘導体 |
JP2005515172A (ja) | 2001-11-02 | 2005-05-26 | グラクソ グループ リミテッド | Hcv阻害剤としての4−(6−員)−ヘテロアリールアシルピロリジン誘導体 |
EP1440068A1 (en) | 2001-11-02 | 2004-07-28 | Glaxo Group Limited | Acyl dihydro pyrrole derivatives as hcv inhibitors |
BRPI0506945A (pt) | 2004-01-30 | 2007-06-12 | Medivir Ab | inibidores de serina protease ns-3 de hcv |
US8329159B2 (en) | 2006-08-11 | 2012-12-11 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
US20140010783A1 (en) * | 2012-07-06 | 2014-01-09 | Hoffmann-La Roche Inc. | Antiviral compounds |
-
2014
- 2014-02-27 US US14/766,872 patent/US9428469B2/en not_active Expired - Fee Related
- 2014-02-27 WO PCT/EP2014/053780 patent/WO2014135422A1/en active Application Filing
- 2014-02-27 RU RU2015136256A patent/RU2015136256A/ru unknown
- 2014-02-27 KR KR1020157024045A patent/KR20150114566A/ko active IP Right Grant
- 2014-02-27 EP EP14710208.1A patent/EP2964637B1/en not_active Not-in-force
- 2014-02-27 BR BR112015021429A patent/BR112015021429A2/pt not_active Application Discontinuation
- 2014-02-27 JP JP2015560619A patent/JP6018715B2/ja not_active Expired - Fee Related
- 2014-02-27 MX MX2015011193A patent/MX2015011193A/es unknown
- 2014-02-27 CN CN201480011399.1A patent/CN105008350B/zh not_active Expired - Fee Related
- 2014-02-27 CA CA2900319A patent/CA2900319A1/en not_active Abandoned
-
2016
- 2016-04-25 HK HK16104702.3A patent/HK1216885A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
WO2014135422A1 (en) | 2014-09-12 |
JP2016510046A (ja) | 2016-04-04 |
US20160009666A1 (en) | 2016-01-14 |
CN105008350A (zh) | 2015-10-28 |
BR112015021429A2 (pt) | 2017-07-18 |
CN105008350B (zh) | 2018-05-08 |
EP2964637B1 (en) | 2017-04-12 |
KR20150114566A (ko) | 2015-10-12 |
HK1216885A1 (zh) | 2016-12-09 |
US9428469B2 (en) | 2016-08-30 |
JP6018715B2 (ja) | 2016-11-02 |
EP2964637A1 (en) | 2016-01-13 |
CA2900319A1 (en) | 2014-09-12 |
MX2015011193A (es) | 2015-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2015136256A (ru) | Противовирусные соединения | |
RU2014142598A (ru) | Новые 4-метилдигидропиримидины для лечения и профилактики инфекции вируса гепатита в | |
JP5593363B2 (ja) | 医薬組成物 | |
RU2017114355A (ru) | Производные нафтиридина в качестве антагонистов альфа v бета 6 интегрина для лечения, в частности, фиброзных заболеваний | |
IL300402A (en) | Oxadiazole fungicides | |
RU2020123547A (ru) | Соединения и композиции для модуляции киназной активности мутантов egfr | |
JP2013535414A5 (ru) | ||
JP2013543896A5 (ru) | ||
JP2013519680A5 (ru) | ||
JP2014530900A5 (ru) | ||
JP2014526501A5 (ru) | ||
RU2005108042A (ru) | Производные бензимидазола | |
JP2015531774A5 (ru) | ||
HRP20230789T1 (hr) | Derivati benzhidroksamske kiseline kao selektivni inhibitori hdac6 | |
JP2007308471A5 (ru) | ||
JP2009532366A5 (ru) | ||
AR074471A1 (es) | Compuesto 5(5-(2-(3-aminopropoxi) - 6 - metoxifenil) -1h- pirazol-3- ilamino ) pirazin -2-carbonitrilo , composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para inhibir chk1 y para tratar cancer | |
JP2012530705A5 (ru) | ||
JP2010265321A5 (ru) | ||
CL2013000884A1 (es) | El compuesto (r)-(e)-2-(4-(2-(5-(1-(3,5-dicloropiridin-4-il)etoxi)-1h-indazol-3-il)vinil)-1h-pirazol-1-il)etanol cristalino, modulador del factor de crecimiento de fibroblastos (fgf); composicion farmaceutica, util en el tratamiento del cancer. | |
AR098031A1 (es) | Combinaciones de compuestos activos que comprenden un derivado de (tio)carboxamida y un compuesto fungicida | |
AR048864A1 (es) | Tabletas dispersables que comprenden un derivado de acido benzoico | |
RU2011134868A (ru) | N-замещенные насыщенные гетероциклические сульфоновые соединения с активностью агонистов рецептора св2 | |
RU2015132105A (ru) | Азоловые производные бензола | |
RU2017145929A (ru) | МОДУЛЯТОРЫ ROR ГАММА(RORγ) |